Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12544353 | Application of glycerol monodecanoate in preparation of hypoglycemic drug or functional food | 🖼🧊📄§ | 2026-02-10 | 2045-05-12 | 0 | 31 |
| 12544332 | Lipid vesicle compositions with penetration enhancing agents | 🖼🧊📄§ | 2026-02-10 | 2042-03-23 | 0 | 31 |
| 12543740 | Micellar disinfectants | 🖼🧊📄§ | 2026-02-10 | 2041-02-26 | 0 | 31 |
| 12544333 | Lipid vesicle compositions with penetration enhancing agents | 🖼🧊📄§ | 2026-02-10 | 2044-02-02 | 0 | 31 |
| 12544406 | Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke | 🖼🧊📄§ | 2026-02-10 | 2036-09-27 | 0 | 31 |
| 12544365 | Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumours | 🖼🧊📄§ | 2026-02-10 | 2042-10-26 | 0 | 31 |
| 12548651 | Identification of clonal neoantigens and uses thereof | 🖼🧊📄§ | 2026-02-10 | 2042-10-11 | 0 | 31 |
| 12545722 | Pharmaceutical compositions targeting immune-mediated processes in neurodegenerative disease | 🖼🧊📄§ | 2026-02-10 | 2044-04-29 | 0 | 31 |
| 12544458 | PAH-modulating compositions and methods | 🖼🧊📄§ | 2026-02-10 | 2043-10-26 | 0 | 31 |
| 12544347 | Anti-cancer combination and a method of therapy using the combination | 🖼🧊📄§ | 2026-02-10 | 2039-09-05 | 0 | 31 |
| 12544355 | Use of monascinol in preparation of fat-reducing product | 🖼🧊📄§ | 2026-02-10 | 2041-07-09 | 0 | 31 |
| 12544408 | Prevention and treatment of kidney failure by administration of fibroblasts and products thereof | 🖼🧊📄§ | 2026-02-10 | 2040-12-22 | 0 | 31 |
| 12545738 | Canine interleukin-4 receptor alpha antibodies | 🖼🧊📄§ | 2026-02-10 | 2040-12-18 | 0 | 31 |
| 12545719 | Neutralizing antibodies to GP120 and their use | 🖼🧊📄§ | 2026-02-10 | 2045-01-23 | 0 | 31 |
| 12545671 | Compound having biological activity such as antiviral activity | 🖼🧊📄§ | 2026-02-10 | 2042-07-14 | 0 | 31 |
| 12545909 | DUX4 RNA silencing using RNA targeting CRISPR-CAS13b | 🖼🧊📄§ | 2026-02-10 | 2039-12-31 | 0 | 31 |
| 12545739 | Compositions and methods for making and using bispecific antibodies | 🖼🧊📄§ | 2026-02-10 | 2038-11-13 | 0 | 31 |
| 12544443 | Photodynamic therapy comprising two light exposures at different wavelengths | 🖼🧊📄§ | 2026-02-10 | 2043-03-22 | 0 | 31 |
| 12544417 | Oral film and stick jelly for improving absorption in the oral mucosa, antioxidant activity, anti-inflammatory activity, and liver function of humans and companion animals | 🖼🧊📄§ | 2026-02-10 | 2042-02-17 | 0 | 31 |
| 12545710 | Multiple antigen presenting immunogenic composition, and methods and uses thereof | 🖼🧊📄§ | 2026-02-10 | 2044-03-20 | 0 | 31 |
| 12545668 | Cyclic amine derivative as agent for promoting advillin function, and novel cyclic amine derivative and pharmaceutical use thereof | 🖼🧊📄§ | 2026-02-10 | 2039-12-26 | 0 | 31 |
| 12545948 | Identification of novel loci in asthma and methods of use thereof for the diagnosis and treatment of asthma | 🖼🧊📄§ | 2026-02-10 | 2037-07-21 | 0 | 31 |
| 12544419 | Targeted amatoxin conjugate for the treatment of solid tumors | 🖼🧊📄§ | 2026-02-10 | 2039-04-12 | 0 | 31 |
| 12545643 | 3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same | 🖼🧊📄§ | 2026-02-10 | 2041-03-09 | 0 | 31 |
| 12544413 | Composition with antibacterial and re-epithelializing action including probiotics | 🖼🧊📄§ | 2026-02-10 | 2040-06-18 | 0 | 31 |
| 12545895 | Protection of beta cells from immune attack | 🖼🧊📄§ | 2026-02-10 | 2043-06-06 | 0 | 31 |
| 12544354 | Mitochondrial permeability transition pore (mPTP)-opening inhibitor, novel compound exhibiting mPTP-opening inhibitory activity, and use therefor | 🖼🧊📄§ | 2026-02-10 | 2040-06-17 | 0 | 31 |
| 12544360 | Pharmaceutical composition for preventing or treating coronavirus disease-19 | 🖼🧊📄§ | 2026-02-10 | 2041-04-27 | 0 | 31 |
| 12544449 | Antisense nucleic acid targeting PCSK9 | 🖼🧊📄§ | 2026-02-10 | 2042-02-03 | 0 | 31 |
| 12544404 | Compositions and methods for treating bone injury | 🖼🧊📄§ | 2026-02-10 | 2039-09-17 | 0 | 31 |
| 12544357 | Compositions and methods for the treatment of Plasmodium falciparum malaria | 🖼🧊📄§ | 2026-02-10 | 2042-02-28 | 0 | 31 |
| 12545706 | Pharmaceutical composition for preventing or treating Behcet's disease and rheumatoid arthritis, containing peptide or mixture thereof as active ingredient | 🖼🧊📄§ | 2026-02-10 | 2040-12-04 | 0 | 31 |
| 12545674 | Crystal of trifluoromethyl/chloro disubstituted sulfonamide selective BCL-2 inhibitor | 🖼🧊📄§ | 2026-02-10 | 2041-04-29 | 0 | 31 |
| 12544447 | Nuclease-dendrimer formulations for Covid-19 and broad-spectrum antiviral therapy and prophylaxis | 🖼🧊📄§ | 2026-02-10 | 2044-03-13 | 0 | 31 |
| 12544409 | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy | 🖼🧊📄§ | 2026-02-10 | 2041-11-17 | 0 | 31 |
| 12544442 | Biocompatible nanomagnetic discs and methods of use thereof | 🖼🧊📄§ | 2026-02-10 | 2039-11-01 | 0 | 31 |
| 12544434 | Recombinant lactic acid bacterium and method thereof for simultaneous treatment and/or prevention of dust mite and cockroach allergies | 🖼🧊📄§ | 2026-02-10 | 2043-06-07 | 0 | 31 |
| 12544422 | Use of gelsolin to treat or prevent lung injury and disease | 🖼🧊📄§ | 2026-02-10 | 2040-11-20 | 0 | 31 |
| 12545730 | Optimized anti-CD3 arm in the generation of t-cell bispecific antibodies for immunotherapy | 🖼🧊📄§ | 2026-02-10 | 2040-12-15 | 0 | 31 |
| 12545735 | Anti-met antibodies, bispecific antigen binding molecules that bind met, and methods of use thereof | 🖼🧊📄§ | 2026-02-10 | 2041-08-25 | 0 | 31 |
| 12545683 | CBP/catenin signaling pathway inhibitors and uses thereof | 🖼🧊📄§ | 2026-02-10 | 2043-04-07 | 0 | 31 |
| 12545704 | Peptide for treating inflammation and wounds | 🖼🧊📄§ | 2026-02-10 | 2042-04-12 | 0 | 31 |
| 12544405 | Fat composition and nutritional composition based thereon | 🖼🧊📄§ | 2026-02-10 | 2040-02-27 | 0 | 31 |
| 12544366 | Combination of endocannabinoid and mTOR inhibitors in the treatment of neuroendocrine neoplasms | 🖼🧊📄§ | 2026-02-10 | 2043-05-17 | 0 | 31 |
| 12545695 | Compounds for inhibiting neovascularization factors and use thereof | 🖼🧊📄§ | 2026-02-10 | 2040-12-16 | 0 | 31 |
| 12544397 | Compositions and methods containing N-acetylcystein and nicotinamide riboside for prevention and treatment of neurological diseases and conditions | 🖼🧊📄§ | 2026-02-10 | 2041-04-01 | 0 | 31 |
| 12545727 | Antibodies specific to human Nectin-2 | 🖼🧊📄§ | 2026-02-10 | 2040-01-13 | 0 | 31 |
| 12544400 | Treatment of myopic progression | 🖼🧊📄§ | 2026-02-10 | 2042-12-13 | 0 | 31 |
| 12545688 | Camptothecin derivative and conjugate thereof | 🖼🧊📄§ | 2026-02-10 | 2040-09-17 | 0 | 31 |
| 12545906 | Methods and compositions for selection of functional aptamers | 🖼🧊📄§ | 2026-02-10 | 2039-09-27 | 0 | 31 |